Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Conditions:   Ewing Sarcoma;   Rhabdomyosarcoma;   Wilms Tumor;   Neuroblastoma;   Hepatoblastoma;   Germ Cell Tumor Intervention:   Drug: Vorinostat Sponsor:   New York Medical College Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2020 Category: Research Source Type: clinical trials